[Osteoporosis].
It is well known that people, especially white people, are getting osteoporosis more often than previously thought. Until now, no direct causative factor has been determined, but genetic factors are very likely to be involved. Usually, affected individuals are initially asymptomatic while the disease process is going on, and they come to the attention of the medical profession only late when their bones are fractured as a result of a simple trauma. Also it is vital to let people know that heavy sports, at times, can be harmful.
Al-Khawajah
F F
FF
Jordanian Hospital, Amman, Jordan. r.hussein@index.com.jo
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000856:Anorexia Nervosa / Q000150:complications; D001172:Arthritis, Rheumatoid / Q000150:complications; D001265:Athletic Injuries / Q000150:complications; D015519:Bone Density; D002116:Calcitonin / Q000627:therapeutic use; D002117:Calcitriol / Q000627:therapeutic use; D002120:Calcium Channel Agonists / Q000627:therapeutic use; D015984:Causality; D004164:Diphosphonates / Q000627:therapeutic use; D050723:Fractures, Bone / Q000209:etiology; D020022:Genetic Predisposition to Disease / Q000453:epidemiology / Q000209:etiology; D006801:Humans; D006961:Hyperparathyroidism / Q000150:complications; D006980:Hyperthyroidism / Q000150:complications; D015212:Inflammatory Bowel Diseases / Q000150:complications; D008594:Menopause, Premature; D010024:Osteoporosis / Q000175:diagnosis / Q000453:epidemiology / Q000209:etiology / Q000628:therapy; D010353:Patient Education as Topic; D020849:Raloxifene Hydrochloride / Q000627:therapeutic use; D020845:Selective Estrogen Receptor Modulators / Q000627:therapeutic use; D013167:Spondylitis, Ankylosing / Q000150:complications; D044465:White People
D000305:Adrenal Cortex Hormones; D002120:Calcium Channel Agonists; D004164:Diphosphonates; D020845:Selective Estrogen Receptor Modulators; D020849:Raloxifene Hydrochloride; D002116:Calcitonin; D002117:Calcitriol